First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea. Kim MH, Choi CM, Lee SY, Park CK, et al. Anticancer Res 2022;42:1615-1622.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim MH, Choi CM, Lee SY, Park CK, et al. First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea. Anticancer Res 2022;42:1615-1622.
PMID: 35220259